Andrew L. Pecora, Director at CANCER GENETICS, INC (CGIX), sold 50,000 shares at $15.11 ($713K) on 2013-11-18, disclosed to the SEC on 2013-11-20.
Open-market sale of $713k CGIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.10 | 29,161 | $411K | 57.6% |
| 2 | $14.40 | 18,839 | $271K | 38.0% |
| 3 | $15.11 | 300 | $5K | 0.6% |
| 4 | $15.51 | 1,700 | $26K | 3.7% |
| Total | $14.27 avg | 50,000 | $713K | 100% |
| Filing → |
| NBS | BUY | 2014-11-25 | $50K | — | Filing → |
| TLOG | BUY | 2014-11-19 | $91K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $186K | — | Filing → |